Abstract
1. 1. Fabry's disease is an X-linked inborn error of glycosphingolipid catabolism. 2. 2. The systemic accumulation of the Fabry lipid, trihexosyl ceramide, results from the deficient activity of the Fabry enzyme, ceramide trihexosidase, an α-galactosidase. 3. 3. Renal transplantation provides active enzyme to correct the metabolic defects in Fabry's disease. 4. 4. "Enzyme transplantation" may provide the enzymatic engineering to correct other inborn errors of metabolism.
Original language | English |
---|---|
Pages (from-to) | 203-211 |
Number of pages | 9 |
Journal | Surgery |
Volume | 72 |
Issue number | 2 |
State | Published - Aug 1972 |
Externally published | Yes |